Fung Candice, Boesmans Werend, Cirillo Carla, Foong Jaime P P, Bornstein Joel C, Vanden Berghe Pieter
Department of Physiology, The University of MelbourneParkville, VIC, Australia.
Laboratory for Enteric Neuroscience (LENS), Translational Research Center for Gastrointestinal Disorders (TARGID), KU LeuvenLeuven, Belgium.
Front Cell Neurosci. 2017 Apr 25;11:118. doi: 10.3389/fncel.2017.00118. eCollection 2017.
The enteric nervous system (ENS) situated within the gastrointestinal tract comprises an intricate network of neurons and glia which together regulate intestinal function. The exact neuro-glial circuitry and the signaling molecules involved are yet to be fully elucidated. Vasoactive intestinal peptide (VIP) is one of the main neurotransmitters in the gut, and is important for regulating intestinal secretion and motility. However, the role of VIP and its VPAC receptors within the enteric circuitry is not well understood. We investigated this in the submucosal plexus of mouse jejunum using calcium (Ca)-imaging. Local VIP application induced Ca-transients primarily in neurons and these were inhibited by VPAC1- and VPAC2-antagonists (PG 99-269 and PG 99-465 respectively). These VIP-evoked neural Ca-transients were also inhibited by tetrodotoxin (TTX), indicating that they were secondary to action potential generation. Surprisingly, VIP induced Ca-transients in glia in the presence of the VPAC2 antagonist. Further, selective VPAC1 receptor activation with the agonist ([K15, R16, L27]VIP(1-7)/GRF(8-27)) predominantly evoked glial responses. However, VPAC1-immunoreactivity did not colocalize with the glial marker glial fibrillary acidic protein (GFAP). Rather, VPAC1 expression was found on cholinergic submucosal neurons and nerve fibers. This suggests that glial responses observed were secondary to neuronal activation. Trains of electrical stimuli were applied to fiber tracts to induce endogenous VIP release. Delayed glial responses were evoked when the VPAC2 antagonist was present. These findings support the presence of an intrinsic VIP/VPAC-initiated neuron-to-glia signaling pathway. VPAC1 agonist-evoked glial responses were inhibited by purinergic antagonists (PPADS and MRS2179), thus demonstrating the involvement of P2Y receptors. Collectively, we showed that neurally-released VIP can activate neurons expressing VPAC1 and/or VPAC2 receptors to modulate purine-release onto glia. Selective VPAC1 activation evokes a glial response, whereas VPAC2 receptors may act to inhibit this response. Thus, we identified a component of an enteric neuron-glia circuit that is fine-tuned by endogenous VIP acting through VPAC1- and VPAC2-mediated pathways.
位于胃肠道内的肠神经系统(ENS)由一个复杂的神经元和神经胶质细胞网络组成,它们共同调节肠道功能。确切的神经胶质细胞回路以及涉及的信号分子尚未完全阐明。血管活性肠肽(VIP)是肠道中的主要神经递质之一,对调节肠道分泌和运动很重要。然而,VIP及其VPAC受体在肠回路中的作用尚未得到充分了解。我们使用钙(Ca)成像技术在小鼠空肠的黏膜下神经丛中对此进行了研究。局部应用VIP主要在神经元中诱导Ca瞬变,并且这些瞬变分别被VPAC1和VPAC2拮抗剂(分别为PG 99 - 269和PG 99 - 465)抑制。这些VIP诱发的神经Ca瞬变也被河豚毒素(TTX)抑制,表明它们继发于动作电位的产生。令人惊讶的是,在存在VPAC2拮抗剂的情况下,VIP在神经胶质细胞中诱导Ca瞬变。此外,用激动剂([K15,R16,L27]VIP(1 - 7)/GRF(8 - 27))选择性激活VPAC1受体主要诱发神经胶质细胞反应。然而,VPAC1免疫反应性与神经胶质细胞标志物胶质纤维酸性蛋白(GFAP)没有共定位。相反,VPAC1表达在胆碱能黏膜下神经元和神经纤维上被发现。这表明观察到的神经胶质细胞反应继发于神经元激活。对纤维束施加一连串电刺激以诱导内源性VIP释放。当存在VPAC2拮抗剂时,诱发了延迟的神经胶质细胞反应。这些发现支持存在一种内在的VIP/VPAC启动的神经元到神经胶质细胞的信号通路。VPAC1激动剂诱发的神经胶质细胞反应被嘌呤能拮抗剂(PPADS和MRS2179)抑制,从而证明了P2Y受体的参与。总体而言,我们表明神经释放的VIP可以激活表达VPAC1和/或VPAC2受体的神经元,以调节嘌呤释放到神经胶质细胞上。选择性激活VPAC1会诱发神经胶质细胞反应,而VPAC2受体可能起到抑制这种反应的作用。因此,我们确定了肠神经元 - 神经胶质细胞回路的一个组成部分,该部分通过内源性VIP通过VPAC1和VPAC2介导的途径进行微调。